$2.24 Billion is the total value of BROADWOOD CAPITAL INC's 7 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 12.5% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
STAA | Sell | STAAR SURGICAL CO | $1,321,296,000 | +31.3% | 8,664,239 | -9.2% | 59.06% | +10.4% |
MNST | MONSTER BEVERAGE CORP NEW | $425,370,000 | +0.3% | 4,656,488 | 0.0% | 19.01% | -15.7% | |
IWM | ISHARES TRrussell 2000 etf | $158,265,000 | +3.8% | 690,000 | 0.0% | 7.07% | -12.7% | |
AXON | AXON ENTERPRISE INC | $134,379,000 | +24.1% | 760,062 | 0.0% | 6.01% | +4.4% | |
LCTX | LINEAGE CELL THERAPEUTICS IN | $96,915,000 | +21.3% | 34,005,379 | 0.0% | 4.33% | +2.0% | |
OCX | ONCOCYTE CORP | $96,297,000 | +10.6% | 16,776,484 | 0.0% | 4.30% | -7.0% | |
AGE | AGEX THERAPEUTICS INC | $4,646,000 | -4.3% | 2,997,156 | 0.0% | 0.21% | -19.4% | |
MNST | Exit | MONSTER BEVERAGE CORP NEWput | $0 | – | -200,000 | -100.0% | -0.97% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-16
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
STAAR SURGICAL CO | 42 | Q3 2023 | 59.1% |
MONSTER BEVERAGE CORP NEW | 34 | Q3 2023 | 49.7% |
ISHARES TR | 33 | Q3 2023 | 14.8% |
ONCOCYTE CORPORATION | 31 | Q2 2023 | 4.6% |
BIOTIME INC | 25 | Q2 2019 | 17.8% |
AXON ENTERPRISE INC | 24 | Q3 2023 | 13.4% |
AGEX THERAPEUTICS INC | 20 | Q3 2023 | 1.5% |
LINEAGE CELL THERAPEUTICS INC | 17 | Q3 2023 | 5.1% |
ASTERIAS BIOTHERAPEUTICS INC | 16 | Q4 2018 | 2.9% |
CYNOSURE INC | 15 | Q4 2016 | 10.4% |
View BROADWOOD CAPITAL INC's complete holdings history.
Latest filings
Type | Filed |
---|---|
4 | 2024-04-15 |
13F-HR | 2024-02-14 |
4 | 2024-02-08 |
4 | 2024-01-10 |
4 | 2024-01-05 |
4 | 2023-11-30 |
13F-HR | 2023-11-14 |
4 | 2023-11-14 |
4 | 2023-11-09 |
4 | 2023-11-06 |
View BROADWOOD CAPITAL INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.